WHO GMP non-compliance – Pharma GMP

Case Study: A GMP Failure That Cost $1 Billion in Recalls

digi — Sun, 07 Sep 2025 12:25:41 +0000

Case Study: A GMP Failure That Cost $1 Billion in Recalls Case Study: A $1 Billion Pharma Recall Caused by GMP Failures Introduction: Why This Topic Matters for GMP Compliance Pharmaceutical recalls not only represent a financial loss but also carry severe implications for patient safety and public trust. Among the most high-profile cases in...

GMP Deviations That Can Trigger Product Recalls

digi — Sat, 06 Sep 2025 03:53:39 +0000

GMP Deviations That Can Trigger Product Recalls GMP Deviations That Lead to Costly Product Recalls Introduction: Why This Topic Matters for GMP Compliance Product recalls are among the most damaging consequences of GMP non-compliance. They not only disrupt supply chains and result in financial loss but also erode patient trust and damage a company’s reputation....

Why Most Pharma Plants Fail GMP Inspections

digi — Wed, 03 Sep 2025 12:18:43 +0000

Why Most Pharma Plants Fail GMP Inspections Key Reasons Behind GMP Inspection Failures in Pharma Plants Introduction: Why This Topic Matters for GMP Compliance Pharmaceutical manufacturers operate under constant scrutiny from global regulators such as the FDA, EMA, WHO, and PIC/S. A successful GMP inspection demonstrates that a facility is capable of producing safe, effective,...

Real-Life Case Studies of GMP Failure in Indian Pharma

digi — Tue, 02 Sep 2025 13:11:44 +0000

Real-Life Case Studies of GMP Failure in Indian Pharma Case Studies Highlighting GMP Failures in Indian Pharmaceutical Companies Introduction: Why This Topic Matters for GMP Compliance India is one of the largest global suppliers of generic medicines, accounting for a significant share of the pharmaceutical exports to regulated markets such as the United States, the...